Early quantification of systemic inflammatory (INF) and cardiovascular disease (CVD) proteins predicts long-term treatment response to Tofacitinib and Etanercept (CVD data set)
Ontology highlight
ABSTRACT: Proteomic profiles of 91 cardiovascular disease proteins were measured in the blood of psoriasis patients both before and after treatment with tofacitanib or etanercept. These proteomic profiles were used to develop statistical classifiers for predicting PASI75 responses to tofacitinib and etancercept
ORGANISM(S): Homo sapiens
PROVIDER: GSE136431 | GEO | 2019/11/22
REPOSITORIES: GEO
ACCESS DATA